LII vs. LLY
LII (Lennox International Inc.) and LLY (Eli Lilly and Company) are both stocks. LII operates in Specialty Industrial Machinery (Industrials), while LLY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, LII returned 15.40%/yr vs 33.71%/yr for LLY. At a 0.25 correlation, their price movements are largely independent.
Performance
LII vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LII achieves a 6.05% return, which is significantly lower than LLY's 7.29% return. Over the past 10 years, LII has underperformed LLY with an annualized return of 15.40%, while LLY has yielded a comparatively higher 33.71% annualized return.
LII
- 1D
- 0.99%
- 1M
- -1.50%
- YTD
- 6.05%
- 6M
- 2.56%
- 1Y
- -6.07%
- 3Y*
- 20.35%
- 5Y*
- 10.02%
- 10Y*
- 15.40%
LLY
- 1D
- 1.57%
- 1M
- 21.37%
- YTD
- 7.29%
- 6M
- 15.58%
- 1Y
- 50.32%
- 3Y*
- 38.07%
- 5Y*
- 39.75%
- 10Y*
- 33.71%
LII vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LII Lennox International Inc. | 6.05% | -19.54% | 37.27% | 89.55% | -24.94% | 19.71% | 13.79% | 12.78% | 6.33% | 37.43% |
LLY Eli Lilly and Company | 7.29% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 16.14% | 40.45% | 17.83% |
Correlation
The correlation between LII and LLY is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 1999 | 0.25 |
The correlation between LII and LLY shifts across timeframes, from 0.12 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
LII:
$17.97B
LLY:
$1.03T
LII:
$22.20
LLY:
$28.14
LII:
23.13
LLY:
40.83
LII:
1.41
LLY:
0.82
LII:
3.44
LLY:
14.28
LII:
14.80
LLY:
33.00
LII:
$5.26B
LLY:
$72.25B
LII:
$1.74B
LLY:
$59.75B
LII:
$1.10B
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LII vs. LLY — Risk / Return Rank
LII
LLY
LII vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lennox International Inc. (LII) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LII | LLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.50 | ||
| Sortino ratioReturn per unit of downside risk | -1.91 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.26 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | -0.18 | 2.14 | -2.32 |
| Martin ratioReturn relative to average drawdown | -0.29 | 5.32 | -5.61 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LII | LLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.18 | 1.33 | -1.50 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 1.23 | -0.91 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.53 | 1.12 | -0.59 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.58 | -0.15 |
Drawdowns
LII vs. LLY - Drawdown Comparison
The maximum LII drawdown since its inception was -62.76%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for LII and LLY.
Loading charts...
Drawdown Indicators
| LII | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.76% | -68.24% | +5.48% |
Max Drawdown (1Y)Largest decline over 1 year | -33.77% | -23.64% | -10.13% |
Max Drawdown (3Y)Largest decline over 3 years | -34.71% | -34.48% | -0.23% |
Max Drawdown (5Y)Largest decline over 5 years | -46.88% | -34.48% | -12.40% |
Max Drawdown (10Y)Largest decline over 10 years | -46.88% | -34.48% | -12.40% |
Current DrawdownCurrent decline from peak | -23.22% | 0.00% | -23.22% |
Average DrawdownAverage peak-to-trough decline | -14.50% | -19.22% | +4.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.72% | 9.49% | +11.23% |
Volatility
LII vs. LLY - Volatility Comparison
Lennox International Inc. (LII) and Eli Lilly and Company (LLY) have volatilities of 9.20% and 9.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LII | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.20% | 9.55% | -0.35% |
Volatility (6M)Calculated over the trailing 6-month period | 25.88% | 27.05% | -1.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.85% | 38.16% | -3.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.05% | 32.54% | -0.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.27% | 30.18% | -0.91% |
Dividends
LII vs. LLY - Dividend Comparison
LII's dividend yield for the trailing twelve months is around 1.01%, more than LLY's 0.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LII Lennox International Inc. | 1.01% | 1.04% | 0.75% | 0.97% | 1.71% | 1.09% | 1.12% | 1.21% | 1.11% | 0.94% | 1.08% | 1.10% |
LLY Eli Lilly and Company | 0.56% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Financials
LII vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Lennox International Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LII vs. LLY - Profitability Comparison
LII - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lennox International Inc. reported a gross profit of 351.30M and revenue of 1.14B. Therefore, the gross margin over that period was 31.0%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.
LII - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lennox International Inc. reported an operating income of 163.50M and revenue of 1.14B, resulting in an operating margin of 14.4%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.
LII - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lennox International Inc. reported a net income of 117.20M and revenue of 1.14B, resulting in a net margin of 10.3%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.
Frequently Asked Questions
LII and LLY have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LLY has higher volatility (9.55%) compared to LII (9.20%). In terms of maximum drawdown, LII dropped -62.76% vs LLY's -68.24%.
LLY currently has the higher Sharpe Ratio (1.33 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LII and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer